HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedEUCTR 2011-005513-37

A PHASE 4, NON-TREATMENT FOLLOW-UP FOR CARDIAC ASSESSMENTS FOLLOWING USE OF SMOKING CESSATION TREATMENTS IN SUBJECTS WITH AND WITHOUT A HISTORY OF PSYCHIATRIC DISORDERS

This historical record does not confirm current site availability.

Historical research recordMultiple countriesAddiction
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Bulgaria · Denmark and 4 more locations
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
8,000
Sponsor
Pfizer Inc., 235 East 42nd Street, New York, NY 10017 US
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Bulgaria, Denmark, Finland, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2011-005513-37
Official title
Show the full official title

A PHASE 4, NON-TREATMENT FOLLOW-UP FOR CARDIAC ASSESSMENTS FOLLOWING USE OF SMOKING CESSATION TREATMENTS IN SUBJECTS WITH AND WITHOUT A HISTORY OF PSYCHIATRIC DISORDERS

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bulgaria · Denmark · Finland

3 more locations
  • Germany
  • Slovakia
  • Spain
Checked Official study record (opens in a new tab)
Registry details
Historical country statuses
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pfizer Inc., 235 East 42nd Street, New York, NY 10017 US.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me